ProShare Advisors’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$27.9K Buy
38,852
+1,007
+3% +$722 ﹤0.01% 2048
2025
Q1
$55.6K Sell
37,845
-12,359
-25% -$18.2K ﹤0.01% 1940
2024
Q4
$222K Buy
50,204
+11,267
+29% +$49.9K ﹤0.01% 1830
2024
Q3
$160K Buy
38,937
+7,764
+25% +$32K ﹤0.01% 1787
2024
Q2
$203K Sell
31,173
-7,710
-20% -$50.3K ﹤0.01% 1523
2024
Q1
$339K Buy
38,883
+2,917
+8% +$25.4K ﹤0.01% 1353
2023
Q4
$411K Buy
35,966
+4,703
+15% +$53.8K ﹤0.01% 1164
2023
Q3
$301K Sell
31,263
-348
-1% -$3.35K ﹤0.01% 1206
2023
Q2
$336K Buy
31,611
+1,195
+4% +$12.7K ﹤0.01% 1198
2023
Q1
$320K Sell
30,416
-3,750
-11% -$39.5K ﹤0.01% 1176
2022
Q4
$423K Buy
34,166
+2,580
+8% +$32K ﹤0.01% 1042
2022
Q3
$328K Sell
31,586
-162
-0.5% -$1.68K ﹤0.01% 1095
2022
Q2
$367K Sell
31,748
-12,258
-28% -$142K ﹤0.01% 1093
2022
Q1
$553K Sell
44,006
-11,105
-20% -$140K ﹤0.01% 1221
2021
Q4
$642K Buy
55,111
+1,692
+3% +$19.7K ﹤0.01% 1292
2021
Q3
$698K Sell
53,419
-13,372
-20% -$175K ﹤0.01% 1031
2021
Q2
$860K Buy
66,791
+1,875
+3% +$24.1K ﹤0.01% 1121
2021
Q1
$726K Buy
64,916
+4,855
+8% +$54.3K ﹤0.01% 1188
2020
Q4
$684K Buy
60,061
+14,732
+33% +$168K ﹤0.01% 1077
2020
Q3
$408K Sell
45,329
-1,825
-4% -$16.4K ﹤0.01% 1024
2020
Q2
$487K Buy
47,154
+16,428
+53% +$170K ﹤0.01% 958
2020
Q1
$310K Sell
30,726
-24,021
-44% -$242K ﹤0.01% 864
2019
Q4
$729K Sell
54,747
-5,122
-9% -$68.2K ﹤0.01% 915
2019
Q3
$514K Sell
59,869
-459
-0.8% -$3.94K ﹤0.01% 977
2019
Q2
$660K Sell
60,328
-20,661
-26% -$226K ﹤0.01% 910
2019
Q1
$918K Buy
80,989
+6,637
+9% +$75.2K 0.01% 799
2018
Q4
$645K Sell
74,352
-13,651
-16% -$118K ﹤0.01% 858
2018
Q3
$1.36M Sell
88,003
-3,000
-3% -$46.4K 0.01% 698
2018
Q2
$1.46M Sell
91,003
-5,127
-5% -$82.1K 0.01% 697
2018
Q1
$1.24M Sell
96,130
-14,836
-13% -$192K 0.01% 753
2017
Q4
$1.39M Buy
110,966
+9,082
+9% +$114K 0.01% 722
2017
Q3
$1.35M Buy
101,884
+5,510
+6% +$72.8K 0.01% 660
2017
Q2
$1.52M Sell
96,374
-6,174
-6% -$97.6K 0.02% 626
2017
Q1
$1.47M Sell
102,548
-25,726
-20% -$368K 0.02% 645
2016
Q4
$1.64M Buy
128,274
+13,149
+11% +$168K 0.02% 611
2016
Q3
$1.53M Sell
115,125
-17,963
-13% -$239K 0.02% 565
2016
Q2
$1.46M Buy
133,088
+2,043
+2% +$22.4K 0.02% 611
2016
Q1
$1.2M Sell
131,045
-12,777
-9% -$117K 0.02% 641
2015
Q4
$1.4M Buy
143,822
+14,119
+11% +$137K 0.02% 624
2015
Q3
$1.13M Sell
129,703
-9,424
-7% -$82.2K 0.02% 640
2015
Q2
$1.41M Sell
139,127
-8,936
-6% -$90.2K 0.02% 631
2015
Q1
$1.98M Buy
148,063
+19,615
+15% +$263K 0.02% 564
2014
Q4
$1.65M Sell
128,448
-2,586
-2% -$33.2K 0.02% 634
2014
Q3
$1.42M Sell
131,034
-25,123
-16% -$273K 0.02% 914
2014
Q2
$2.01M Sell
156,157
-79,239
-34% -$1.02M 0.03% 746
2014
Q1
$2.43M Buy
235,396
+176,041
+297% +$1.82M 0.03% 633
2013
Q4
$577K Sell
59,355
-50,801
-46% -$494K 0.01% 1054
2013
Q3
$1.09M Buy
110,156
+23,969
+28% +$238K 0.03% 805
2013
Q2
$718K Buy
+86,187
New +$718K 0.01% 1063